Toll-Like Receptors are critical in controlling colonic inflammation and cancer
2011
The Role of SIGIRR in Colonic Inflammation and Cancer
publication
Author Information
Author(s): Xiao Hui, Yin Weiguo, Khan Mohammed A, Gulen Muhammet F, Vallance Bruce A, Li Xiaoxia
Primary Institution: Institut Pasteur of Shanghai
Hypothesis
The study investigates the role of SIGIRR in regulating TLR signaling and its impact on colonic tumorigenesis.
Conclusion
The study found that SIGIRR is a critical tumor suppressor that controls tumorigenesis by inhibiting TLR-induced mTOR and NFkB pathways in the colonic epithelium.
Supporting Evidence
- Lack of SIGIRR led to increased genetic instability and colonic polyposis in mice.
- Elevated colonic tumorigenesis in mice was dependent on commensal microbes.
- SIGIRR modulates TLR-mediated tumor initiation through the Akt-mTOR axis.
- Rapamycin prevented microadenoma and polyp formation in the studied mice.
- Re-expression of SIGIRR ameliorated intestinal tumorigenesis.
Takeaway
This study shows that a protein called SIGIRR helps prevent cancer in the gut by controlling how the body responds to germs.
Methodology
The study used Apcmin/+/Sigirr-/- mice to investigate the effects of SIGIRR on tumorigenesis and TLR signaling.
Want to read the original?
Access the complete publication on the publisher's website